Company: SMNR
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027319
Chunk: 566

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-02
Form: 10-K
Item: Item 2
Chunk 566
---
 furnish
supplemental copies of the unredacted exhibit upon request by the SEC.

(1)Filed
as an exhibit to Amendment No. 1 to the Registration Statement on Form S-1 filed with the SEC on March 22, 2022 (File No. 333-263123).

(2)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on April 12, 2022 (File No. 001-41351).

(3)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on October 11, 2023 (File No. 001-41351).

(4)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on April 12, 2023 (File No. 001-41351).

(5)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on July 13, 2023 (File No. 001-41351).

(6)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on November 20, 2023 (File No. 001-41351).

(7)Filed
as an exhibit to the Annual Report on Form 10-K filed with the SEC on March 17, 2023 (File No.001-41351).

(8)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on July 10, 2024 (File No. 001-41351).

(9)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on September 5, 2024 (File No. 001-41351).

(10)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on August 9, 2024 (File No. 001-41351).

(11)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on June 27, 2024 (File No. 001-41351).

(12)Filed
as an exhibit to the Current Report on Form 8-K filed with the SEC on July 17, 2024 (File No. 001-41351).

(13)Filed
as an exhibit to the Annual Report on Form 10-K filed with the SEC